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Rapid, single-subject genotyping 
to predict red blood cell antigen 
expression
s.l. slezaK, s. aDams, h. lee-strOKa, J.e. martin, l. CaruCCiO, anD D.F. strOnCeK
Genotyping is useful to predict the expression of those RBC 
antigens for which antisera are difficult to obtain and to de-
termine the probable phenotype of highly transfused patients, 
and it can be used to test stored DNA when a blood sample is 
not available.  This study assessed a sequence-specific primer 
(SSP)-based genotyping system for blood group alleles suitable 
for the rapid testing of a small number of samples and assessed 
the use of stored whole blood.  Genomic DNA was isolated 
from fresh and 1- and 2-week-old stored blood from 20 donors 
with known ABO and Rh phenotypes and was used for ABO, 
RHD, and RHCE genotyping using SSPs.  The amplicons were 
analyzed using gel electrophoresis and a novel microfluidic on-
chip electrophoresis system.  Analysis of DNA from fresh and 
1- and 2-week-old blood by SSP and gel electrophoresis yielded 
the correct ABO, RHD, and RHCE type in all samples, but with 
DNA from 2-week-old stored blood the amplicons were more 
difficult to visualize.  Analysis of the same samples with the 
SSP on-chip electrophoresis assay correctly typed all samples 
except for one RHCE typing discrepancy of a fresh sample and 
one RHCE typing discrepancy of a 2-week-old sample.  Analysis 
of amplicons by on-chip electrophoresis required one tenth 
the DNA that gel electrophoresis did and could be completed 
within 30 minutes compared with 2 hours with gel electro-
phoresis.  Amplicons were also more readily visualized with 
on-chip electrophoresis.  Fresh and 1- and 2-week-old samples 
could be ABO and RH genotyped with SSP.  Analysis using 
on-chip electrophoresis was easier and more rapid than that 
using gel electrophoresis, but test reliability was slightly more 
variable.  Immunohematology 2008;24:154–159.
As a result of the lack of available antisera for the 
typing of certain antigens and the need to perform 
higher resolution typing, molecular (DNA-based) as-
says have been developed to predict the expression 
of HLA, platelet, and neutrophil antigens.1–6  The mo-
lecular basis of almost all clinically significant RBC 
antigens is known, and methods for the analysis of 
blood group genotypes have been described.7–13  RBC 
genotyping is useful for predicting the phenotype of 
clinically important RBC antigens for which antisera 
are difficult to obtain.  RBC genotyping is also useful 
for predicting the phenotypes of patients who are 
multiply transfused or whose RBCs are not available 
but their genomic DNA has been cryopreserved or 
otherwise saved.8–11,14
The method favored for genotyping varies among 
different types of laboratories.  Large blood collec-
tion and processing centers require high-throughput 
systems to genotype large numbers of donors. 
Transfusion services and immunohematology refer-
ence laboratories are required to rapidly test one or 
a few patients or donors.  Large blood centers will 
likely be using fresh blood samples for genotyping, 
whereas transfusion services or reference laborato-
ries will be asked to test both fresh and stored blood 
samples.
The purpose of this study was to assess a geno-
typing system for blood groups that should be useful 
for laboratories that are required to rapidly type a few 
samples.  A commercially available sequence-specific 
primer (SSP) method was used for ABO, RHD, and 
RHCE genotyping.  To analyze the amplicons, a stan-
dard gel electrophoresis method was compared with 
a novel microfluidic on-chip electrophoresis method. 
Because on-chip electrophoresis allows for amplicon 
analysis within minutes rather than the hours required 
for gel electrophoresis, it may be a more convenient 
assay.  As it is sometimes necessary to test patient 
samples collected and stored for several days, in addi-
tion to testing genomic DNA isolated from fresh blood 
samples, genomic DNA isolated from blood stored for 
1 and 2 weeks at 2° to 6°C was also tested.
Materials and Methods
Study Design
Whole blood, 5 mL, from healthy subjects, was 
collected into EDTA and was used for ABO, RHD, 
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and RHCE genotyping and to determine the ABO 
and Rh phenotype.  RBCs were serologically tested 
within 24 hours of sample collection.  Genomic 
DNA was isolated from the blood samples within 48 
hours of collection and from the same blood samples 
stored at 2° to 6°C for 1 and 2 weeks.  The isolated 
DNA was amplified using SSP PCR, and the amplified 
DNA from each reaction was analyzed by both gel 
and on-chip electrophoresis.  If samples generated 
unclear results, the SSP PCR and the electrophoresis 
were repeated.
RBC Phenotyping
RBCs were typed for ABO and D using gel 
microcolumns (Ortho-Clinical Diagnostics, Inc., 
Raritan, NJ) and for C, c, E, and e antigens using a 
tube agglutination method.  The A2 phenotype was 
determined using an anti-A1 lectin by standard tube 
method (Immucor, Inc., Norcross, GA).
DNA Isolation
DNA was isolated from the whole blood samples 
using spin columns (QIAamp DNA Blood Mini Kit, 
QIAGEN, Valencia, CA) according to manufacturer’s 
instructions.  After isolation, DNA concentration was 
determined by spectrophotometric analysis and the 
DNA was stored in QIAamp Elution Buffer at 2° to 
6°C until use.
ABO and RH Genotyping
Genotyping for ABO (ABO-Type, BAGene, 
Biologische Analysensystem GmbH, Lich, Germany), 
RHD, and RHCE (RH-Type, BAGene) was performed 
using SSP via PCR methods.12,15  Approximately 100 
ng/μL DNA was used for SSP amplification according 
to manufacturer’s instructions.  The PCR conditions 
included an initial denaturation step for 5 minutes 
at 96°C, followed by 5 cycles of 10 seconds at 96°C, 
and 60 seconds at 70°C.  The next 10 cycles were 10 
seconds at 96°C, 50 seconds at 65°C, and 45 seconds 
at 72°C.  The final 15 cycles were 10 seconds at 96°C, 
50 seconds at 61°C, and 45 seconds at 72°C, and were 
followed by a final extension step of 5 minutes at 
72°C.
The amplicons were analyzed by gel and on-chip 
electrophoresis. Standard gel electrophoresis was 
carried out on a 2% analytical gel prepared with 
SeaKem GTG agarose (BMA, Rockland, ME) and 1× 
TBE buffer (Cambrex Bio Sciences Rockland, Inc, 
Rockland, ME).  After SSP PCR, the samples (9 μL) 
were electrophoresed at a constant 100 V for 75 min-
utes in a Gibco-BRL (Carlsbad, CA) 11.14 horizontal 
gel apparatus.  The bromophenol blue dye front ran 
approximately 4 cm.  To determine the size of the 
final amplicons 7 μL of Ready-to-Load 100bp Plus 
DNA ladder (Qiagen) was loaded in a separate lane.
On-chip electrophoresis was performed using 
lab-on-a-chip technology, which analyzes a very 
small volume of fluid in microfluidic channels etched 
in glass or plastic.16  After SSP PCR, 1 μL from 
each sample was loaded into one well of a 16-well 
chip (DNA chips, Agilent Technologies, Waldbronn 
Germany; Fig. 1).  Only 12 of the 16 wells on the 
chip could be used for sample analysis.  One of the 
remaining wells was loaded with 1 μL of DNA ladder, 
and three wells must be loaded with 9 μL of gel/dye 
mix (Agilent Technologies).  The gel/dye mix is a 
sieving polymer matrix and fluorescent intercalating 
dye that is loaded into the appropriate wells on the 
chip and is forced through the microfluidic capillaries 
by applying pressure with a 1-mL syringe.  With the 
capillaries filled, the chip acts as an electrical circuit, 
and the charged DNA sample can be separated by 
size as it is driven through the polymer matrix by a 
voltage gradient.  The fluorescent dye is detected by 
laser-induced fluorescence.17,18  The chip was analyzed 
for 20 to 30 minutes with a bench-top chip reader 
(2100 Bioanalyzer, Agilent Technologies) linked to a 
computer, which produced a gel-like image (Fig. 1).
Fig. 1. Microfluidic chip-based DNA analysis.  Electrophoresis is 
performed on a disposable chip with 16 wells (A).  Amplified 
DNA is loaded in up to 12 wells of the 16-well chip (B).  DNA 
ladder is loaded into one well, and gel/dye is loaded into 
three wells.  The chip is analyzed for 20 to 30 minutes in the 
desktop reader-analyzer (C), and a gel-like image is displayed 
by the computer (D).
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Results
Testing of Fresh Samples
Blood samples were tested from 20 donors (Table 
1); 9 were group O, 7 A, 3 B, and 1 AB.  RhD and 
RhCE phenotypes were also determined for the 20 
donors; the sample group included 15 D+ and 5 
D– samples (Table 1).
ABO genotyping
ABO genotyping of the 20 samples using ge-
nomic DNA isolated from fresh blood and analyzed 
by gel electrophoresis produced 2 samples that could 
not be interpreted.  In one sample, all amplicons 
on the entire gel were poorly visualized, and in the 
other sample, the control amplicon in lane 2 was 
not detected.  On-chip electrophoresis was able to 
provide better resolution of weak bands, but it was 
also more likely to detect additional bands, such 
as primer-primer dimers, that were not resolved in 
Table 1. Race, ABO group, and RhD and RhCE phenotypes of the 20 
donors tested
Race Number (%)
Caucasian 13 (65%)
African American 3 (15%)
Asian 3 (15%)
Other 1 (5%)
ABO group
O 9 (45%)
A 7 (35%)
B 3 (15%)
AB 1 (5%)
RhD and RhCE phenotype
D, C, c, e 7 (35%)
D, C, e 3 (15%)
D, c, E, e 1 (5%)
D, C, c, E, e 2 (10%)
D, c, e 2 (10%)
c, e 5 (25%)
Fig. 2. Comparison of gel electrophoresis with on-chip electrophoresis for ABO genotyping with the use of sequence-specific primers (SSP). 
Genomic DNA from donor 10 was isolated from freshly collected peripheral blood leukocytes, and ABO genotype was determined by 
SSP.  The amplicons were analyzed by agarose gel electrophoresis (A) or on-chip electrophoresis (B).  Results based on amplification with 
primers specific for O1 (134 bp), O2 (194 bp), B (195 bp), and A2 (172 bp) alleles are shown in lanes 1, 3, 5, and 7, respectively.  Results based 
on amplification with primers reactive for all alleles except O1 (133 bp), O2 (193 bp), B (194 bp), and A2 (173 bp) are shown in lanes 2, 4, 6, 
and 8, respectively.  Internal control primers specific for human growth hormone (HGH) are shown in all lanes, and produce an amplicon 
of 434 bp.  Bands with weak resolution on the gel were more clearly resolved by the on-chip method; however, the correct genotype was 
determined through repeat analysis with either method.  Bands produced by allele-specific primer pairs are marked with an asterisk (*), 
and those corresponding to primer-primer dimers are shown by an arrow as are the HGH control bands.  Labels on the bottoms of the gels 
indicate the allele(s) recognized by the primers in each lane.
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the traditional gels (Fig. 2).  When the amplicons 
from the same 20 donors were analyzed by on-chip 
electrophoresis, the results from 6 of the 20 subjects 
were difficult to interpret owing to problems with 
additional or smeared bands, or absent control am-
plicons in one or more lanes (Table 2).  Repeat testing 
of these 8 samples yielded accurate ABO genotyping 
results in all 20 samples with both gel and on-chip 
electrophoresis.
RHD and RHCE genotyping
The DNA isolated from fresh blood was also 
used for RH genotyping assays, which yielded results 
similar to those produced by ABO genotyping.  Of 
the 20 samples, 1 sample was difficult to interpret af-
ter standard gel electrophoresis and required repeat 
analysis because of a very weak control band in one 
lane.  When the same 20 samples were analyzed by 
on-chip electrophoresis, 3 samples were of poor qual-
ity, and necessitated repeat analyses.  An additional 
sample yielded an RHCE genotype, RHCE*Ce/Ce, 
that did not agree with the reported C+c+e+ Rh phe-
notype, and the RHCE*Ce/ce genotype obtained with 
gel electrophoresis.  Repeat genotyping analysis of 
the sample with on-chip electrophoresis also yielded 
a genotype of RHCE*Ce/ce.
Testing of Stored Samples
ABO genotyping
On testing of the 1-week-old samples, the ABO 
genotyping assay yielded high-quality, accurate re-
sults, and repeat testing was required for only 1 of 
the 20 samples in both the gel and on-chip electro-
phoresis (Table 2).  In general, the quality of both gel 
and on-chip electrophoresis analysis of DNA from 
1-week-old samples was as good as or better than 
that obtained using DNA from fresh samples.
ABO genotyping results were more difficult to 
interpret using DNA isolated from 2-week-old blood 
samples, but generally the results of analysis with 
on-chip electrophoresis were better than with gel 
electrophoresis.  ABO genotyping performed with 
DNA from blood stored for 2 weeks using gel electro-
phoresis resulted in five poor-quality samples owing 
to the absence of control amplicons, or both control 
and test amplicons.  On-chip electrophoresis analysis 
resulted in difficult interpretation of three samples 
as a result of technical problems with a single lane. 
Generally, visualization of control and test amplicons 
with on-chip electrophoresis was superior to that 
with gel electrophoresis.
RHD and RHCE genotyping
RHD and RHCE genotyping could be performed 
with 1- and 2-week-old samples.  The results of RH 
genotyping using DNA from 1-week-old samples 
were similar to those obtained using DNA from fresh 
blood.  However, in some cases the results of RHD 
and RHCE genotyping using DNA from 2-week-old 
samples were more difficult to interpret, especially 
with on-chip electrophoresis.
When DNA from the stored samples was 
genotyped for RHD and RHCE using the gel elec-
trophoresis system, four of the 1-week-old samples 
required repeat analyses, and none of the 2-week-
old samples necessitated repetition.  The 1-week-old 
samples required repeat analyses because of missing 
or weak control amplicons or both control and test 
amplicons in one or more lanes.
Of the eight stored samples that required addi-
tional RHD and RHCE genotyping with the on-chip 
electrophoresis system, two were 1 week old, and six 
were 2 weeks old.  Seven of these samples required 
repeat testing as a result of weak or missing control 
or test amplicons, presence of extraneous bands, or 
poor amplicon alignment with the DNA ladder.  In 
addition, one of the 2-week-old samples yielded a 
false-positive amplicon in a single lane that resulted 
in an incorrect RHCE genotype (RHCE*CWe/ce) rather 
than the correct RHCE*Ce/ce genotype.  However, on 
analysis using gel electrophoresis, as well as analysis 
of fresh and 1-week-old stored samples with both 
methods, the correct genotype was obtained.  This 
suggests that the band responsible for the errone-
ous genotype result with the on-chip assay was an 
artifact not detected by traditional electrophoresis.
Discussion
We found that an SSP method could be used to 
determine ABO, RHD, and RHCE genotypes using 
Table 2. Number of blood samples from 20 donors that resulted in 
ABO, RHD, and RHCE genotyping data that were difficult to 
interpret: comparison of the results of testing DNA isolated 
from fresh and 1- and 2-week-old samples
 Gel On-chip 
 electrophoresis electrophoresis
Source of DNA ABO	 RHD/CE	 ABO	 RHD/CE
Fresh blood 2 1 6 4
1-week-old blood 1 4 1 2
2-week-old blood 5 0 3 6
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leukocyte genomic DNA isolated from fresh whole 
blood and whole blood stored for 1 and 2 weeks at 
2° to 6°C.  Similar DNA yields were obtained after 
isolation at each of these times.  Several samples had 
to be tested a second time because the initial results 
of either gel or on-chip electrophoresis were difficult 
to interpret.  This was true for fresh and for 1- and 
2-week-old samples.
The results of genotyping DNA isolated from 2-
week-old blood were no less accurate, but they were 
more difficult to visualize than the results from fresh 
and 1-week-old blood.  Amplicons from DNA isolated 
from 2-week-old blood tended to be weaker and, in 
general, more poorly visualized in gel electrophoresis 
than in on-chip electrophoresis.
Genotyping with SSP and gel electrophoresis was 
accurate for all whole blood samples that were fresh 
and 1 and 2 weeks old.  Among the 120 ABO and 
RHD plus RHCE genotypes performed with on-chip 
electrophoresis, 2 were discrepant.  Both involved 
RHCE genotyping, one using DNA from fresh blood, 
and the other using DNA from 2-week-old blood.
The on-chip electrophoresis technology is well 
suited for the rapid genotype analysis of a single 
patient.  In comparison to gel electrophoresis, the 
on-chip method requires smaller sample size, can 
be carried out in minutes rather than hours, and is 
much easier to perform.  However, the on-chip elec-
trophoresis system used in this study is limited to the 
analysis of 12 amplicons at a time: enough amplicons 
to analyze ABO, but just short of the 13 amplicons 
required for RHD and RHCE analysis from a single 
subject.  If both ABO and RHD/RHCE genotyping 
must be performed, the on-chip electrophoresis must 
be executed serially two times.  Most gels used for 
electrophoresis also have a limited number of lanes, 
but multiple gels can be run simultaneously.
Although on-chip electrophoresis was able to better 
resolve amplicons, additional extraneous bands were 
more likely to be present than in gel electrophoresis. 
In addition, the on-chip electrophoresis was some-
what less technically reliable than gel electrophoresis. 
On-chip electrophoresis occasionally produced lanes 
that could not be analyzed as a result of amplicon 
absence or smearing, or the appearance of superflu-
ous bands.  As a result, when the PCR amplicon is 
of good quality, repeat electrophoresis is more likely 
required with on-chip electrophoresis than with gel 
electrophoresis.  Fortunately, on-chip electrophoresis 
requires approximately one tenth the postamplification 
DNA that gel electrophoresis does, and if on-chip 
electrophoresis is used exclusively, enough DNA is 
produced by the SSP kits for multiple analyses.
The instrument for on-chip electrophoresis that 
was used in this study was not made for the analysis 
of clinical samples.  However, a similar microfluidic 
capillary electrophoresis system designed specifically 
for the automated high-throughput analysis of clinical 
samples is now available (eGene HLA SSP, eGene Inc, 
Ivrine, CA).  This system will likely be more reliable 
then the one used in this study and results will likely 
be easier to interpret.  The system contains modules 
that allow for optimal visualization of bands of a wide 
variety of specific sizes and intensities.  In addition, 
the system is specifically designed for clinical testing 
rather than for use in the research laboratory, and 
we expect that the performance will be more robust. 
This system will automatically analyze 96 amplicons 
in less than 30 minutes and thus will allow the rapid 
analysis of multiple samples.
The analysis of the amplicons with on-chip 
electrophoresis was convenient, but a specialized in-
strument is required to analyze the microchips.  We 
prepared our own agarose gels for electrophoresis; 
however, the time and labor involved with gel elec-
trophoresis can be reduced by purchasing precast 
gels. Low-cost electrophoresis equipment is available 
for use with precast gels.
In addition to the SSP method used in this study, 
a sequence-specific oligonucleotide probe (SSOP) 
method that uses microparticles and slides is available 
for genotype determination of blood groups.13,19,20 
In general, SSOP genotyping methods are more 
convenient for high-throughput testing; however, the 
SSOP method requires specialized equipment and 
staff training on equipment use.  In addition, some 
high-throughput assays are only available in multiple 
test platforms, so reagents are wasted if only a single 
sample is tested.
The use of SSP methods like the one used in 
this study with on-chip or gel electrophoresis is well 
suited to the needs of a transfusion service, reference 
laboratory, or blood collection center that is required 
to genotype an occasional patient or donor.  The SSP 
method uses equipment available in most laboratories: 
thermocyclers and electrophoresis equipment.  The 
use of on-chip electrophoresis rather than agarose 
gel electrophoresis makes the SSP method especially 
fast and convenient for testing a limited number of 
samples.
I M M U N O H E M AT O L O G Y,  V O L U M E  2 4 ,  N U M B E R  4 ,  2 0 0 8  159
Rapid, single-subject genotyping
In conclusion, ABO and RHD plus RHCE geno-
typing with SSPs was successful with genomic DNA 
isolated from fresh and 1-week-old blood samples. 
DNA from 2-week-old whole blood samples could also 
be used, but in some cases the results were difficult to 
visualize. Analysis using on-chip electrophoresis was 
easier and more rapid than gel electrophoresis, but 
test reliability was slightly more variable. ABO, RHD, 
and RHCE genotyping with SSPs is well suited for 
testing individual donors and patients, and is more 
convenient when used with on-chip electrophoresis.
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